BiotechTube

Test formulation + Reference formulation

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hypogonadism

Conditions

Hypogonadism

Trial Timeline

Jan 19, 2019 → Apr 2, 2020

NCT ID
NCT03792477

About Test formulation + Reference formulation

Test formulation + Reference formulation is a phase 1 stage product being developed by Pfizer for Hypogonadism. The current trial status is completed. This product is registered under clinical trial identifier NCT03792477. Target conditions include Hypogonadism.

What happened to similar drugs?

6 of 19 similar drugs in Hypogonadism were approved

Approved (6) Terminated (3) Active (12)
✅Topical Testosterone SolutionEli LillyApproved
✅AndroGel® + PlaceboAbbVieApproved
✅AndroGel 1.62%AbbVieApproved
✅Testosterone Undeconate (Nebido, BAY86-5037) + PlaceboBayerApproved
✅NEBIDO + PLACEBOBayerApproved
✅JatenzoICON plc.Approved
🔄Testosterone Solution + Placebo SolutionEli LillyPhase 3

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT03792477Phase 1Completed

Competing Products

20 competing products in Hypogonadism

See all competitors
ProductCompanyStageHype Score
Topical Testosterone SolutionEli LillyApproved
43
Testosterone Solution + Placebo SolutionEli LillyPhase 3
40
Testosterone MD-LotionEli LillyPhase 2
35
Testosterone MD-LotionEli LillyPhase 3
40
Testosterone MD-LotionEli LillyPhase 3
40
Testosterone Gel 1.62% + Testosterone Gel 1.62%AbbViePhase 1
29
ABT-SLV176AbbViePhase 3
32
AndroGel® + PlaceboAbbVieApproved
43
AndroGel 1.62%AbbVieApproved
43
Recombinant human luteinizing hormone (r-hLH) + Recombinant human follicle-stimulating hormone (r-hFSH) + Human chorionic gonadotropin (hCG)MerckPhase 3
40
Oral testosterone undecanoate (Andriol) + PlaceboMerckPhase 2
35
Reference: Follitropin alfa + ZoladexMerckPhase 1
29
Testosterone + Alendronate + Placebo Alendronate + Placebo TestosteroneMerckPhase 2
27
Testosterone Enanthate + FinasterideMerckPhase 2
35
Testim 1% (testosterone gel) + PlaceboMerckPhase 2
27
Investigational new drug company code: BGS649 + PlaceboNovartisPhase 2
27
Testosterone ProductBayerPre-clinical
23
Testosterone undecanoate (TU) - NebidoTMBayerPhase 3
37
Testosterone Undeconate (Nebido-R, BAY86-5037)BayerPre-clinical
23
Testosterone Undeconate (Nebido, BAY86-5037) + PlaceboBayerApproved
32